Karyopharm Therapeutics Inc (KPTI)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 33.58M | 38.7M | 37.58M | 36.01M | 33.75M | 33.13M | 42.79M | 38.78M |
営業利益 | -33.87M | -30.9M | -29.57M | -31.26M | -37.81M | -33.76M | -28.12M | -26.28M |
税引前収入 | -38.43M | -34.07M | -32.5M | -34.49M | -41.71M | -37.29M | 23.86M | -32.04M |
純利益 | -38.51M | -34.13M | -32.63M | -34.51M | -41.84M | -37.36M | 23.79M | -32.07M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -33.88M | -31.16M | -29.54M | -31.17M | -38.02M | -33.56M | -13.82M | -22.49M |
EBITDA | -33.76M | -30.61M | -29.49M | -31.18M | -37.73M | -33.67M | -28.03M | -26.2M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 154k | 1.61M | 30.34M | 40.89M | 108.09M | 209.82M | 157.07M | 146.03M |
営業利益 | -110.73M | -130.54M | -179.88M | -189.28M | -171.85M | -98.27M | -142.2M | -129.54M |
税引前収入 | -109.44M | -128.92M | -178.38M | -199.55M | -195.96M | -123.82M | -164.92M | -142.78M |
純利益 | -109.58M | -128.98M | -178.41M | -199.59M | -196.27M | -124.09M | -165.29M | -143.1M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.616 | -2.604 | -2.933 | -3.053 | -2.655 | -1.638 | -1.46 | -1.249 |
EBIT | -110.72M | -130.56M | -179.89M | -189.33M | -171.84M | -98.36M | -142.29M | -129.9M |
EBITDA | -110.02M | -129.83M | -179.15M | -188.3M | -170.88M | -97.48M | -141.58M | -129.01M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約